💊Glycemic Decision Engine (GDE)

The Glycemic Decision Engine (GDE) is an evidence-based clinical decision-support tool designed to assist healthcare professionals in selecting the most appropriate oral medications for patients with Type 2 Diabetes Mellitus (T2DM). It integrates patient-specific factors with current diabetes management guidelines to generate safe, personalized, and guideline-concordant treatment recommendations.

🔹 Purpose

This tool helps clinicians streamline the complex process of choosing oral antidiabetic therapy by matching individual patient profiles with optimal drug classes and combinations. It supports rational prescribing, improves treatment consistency, and enhances glycemic outcomes.

🔹 How It Works

The selector analyzes key clinical inputs such as:

• HbA1c level and glycemic target

• Duration of diabetes

• Body mass index (BMI)

• Renal function (eGFR)

• Presence of cardiovascular disease (ASCVD)

• Heart failure or CKD status

• Risk of hypoglycemia

• Weight considerations

• Cost sensitivity and access

Using guideline-based algorithms (e.g., ADA/EASD aligned logic), the tool recommends the most suitable oral hypoglycemic agents and escalation pathways.

🔹 Key Features

• Personalized OHA selection based on patient phenotype

• First-line and add-on therapy guidance

• Renal dose safety checks

• Hypoglycemia risk stratification

• Weight impact considerations

• Cardio-renal benefit prioritization

• Contraindication alerts

• Stepwise treatment escalation pathway

• Quick clinical summary output

🔹 Typical Users

• Endocrinologists

• General physicians

• Diabetologists

• Nurse practitioners

• Telemedicine platforms

• Medical residents and students

🔹 Benefits

• Promotes evidence-based diabetes care

• Reduces prescribing variability

• Improves safety in renal and cardiac patients

• Saves clinical decision time

• Supports guideline adherence

• Enhances individualized therapy selection

⚠️ Disclaimer

This tool is intended for educational and clinical decision-support purposes only. Final treatment decisions should always be based on clinician judgment and current local guidelines.